Insulin inhibits glucose production by a direct effect in diabetic depancreatized dogs during euglycemia

Author:

Gupta Neehar1,Sandhu Harmanjit1,Goh Tracy1,Shah Keyur1,Wiesenthal Stephanie R.1,Yoshii Hidenori2,Chong Victor1,Lam Tony K. T.1,Haber C. Andrew1,Williams Wendy3,Tchipashvili Vaja1,Giacca Adria14

Affiliation:

1. Departments of Physiology and

2. Department of Medicine, Juntendo University, Tokyo 113-0033, Japan

3. Division of Comparative Medicine, University of Toronto, Toronto, Ontario M5S 1A8, Canada; and

4. Medicine, and

Abstract

In our previous studies in nondiabetic dogs and humans, insulin suppressed glucose production (GP) by both an indirect extrahepatic and a direct hepatic effect. However, insulin had no direct effect on GP in diabetic depancreatized dogs under conditions of moderate hyperglycemia. The present study was designed to investigate whether insulin can inhibit GP by a direct effect in this model under conditions of euglycemia. Depancreatized dogs were made euglycemic (∼6 mmol/l), rather than moderately hyperglycemic (∼10 mmol/l) as in our previous studies, by basal portal insulin infusion. After ∼100 min of euglycemia, a hyperinsulinemic euglycemic clamp was performed by giving an additional infusion of insulin either portally (POR) or peripherally at about one-half the rate (½ PER) to match the peripheral venous insulin concentrations. The greater hepatic insulin load in POR resulted in greater suppression of GP (from 16.5 ± 1.8 to 12.2 ± 1.6 μmol · kg−1 · min−1) than ½ PER (from 17.8 ± 1.9 to 15.6 ± 2.0 μmol · kg−1 · min−1, P < 0.001 vs. POR), consistent with insulin having a direct hepatic effect in suppressing GP. We conclude that the direct effect of insulin to inhibit GP is present in diabetic depancreatized dogs under conditions of acutely induced euglycemia. These results suggest that, in diabetes, the prevailing glycemic level is a determinant of the balance between insulin's direct and indirect effects on GP.

Publisher

American Physiological Society

Subject

Physiology (medical),Physiology,Endocrinology, Diabetes and Metabolism

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3